Skip to main content
. 2017 Jul 17;7:5571. doi: 10.1038/s41598-017-06004-6

Table 2.

Utility weights by health states related to colorectal cancer.

Variable HS 1 HS 2 HS 3 HS 4 HS 5 HS 6 HS 7
Total N 415 402 396 407 422 392 381
Mean ± SD 0.76 ± 0.31 0.67 ± 0.32 0.62 ± 0.33 0.57 ± 0.32 0.59 ± 0.31 0.57 ± 0.31 0.47 ± 0.32
Median 0.90 0.80 0.75 0.65 0.65 0.65 0.45
1st quartile 0.60 0.35 0.30 0.30 0.30 0.30 0.20
2nd quartile 0.90 0.80 0.75 0.65 0.65 0.65 0.45
3rd quartile 1.00 0.95 0.90 0.85 0.85 0.84 0.75
Gender Man 0.82 0.72 0.70 0.62 0.62 0.61 0.47
Woman 0.79 0.67 0.61 0.57 0.59 0.57 0.43
Age group (years) 19–29 0.78 0.73 0.66 0.63 0.63 0.63 0.49
30–39 0.81 0.64 0.64 0.56 0.60 0.58 0.46
40–49 0.84 0.68 0.68 0.59 0.62 0.60 0.42
50–59 0.80 0.71 0.67 0.58 0.60 0.56 0.43
≥60 0.81 0.71 0.63 0.63 0.60 0.58 0.46
Education level High school or below 0.81 0.69 0.64 0.60 0.59 0.57 0.43
College or above 0.81 0.69 0.68 0.59 0.64 0.62 0.48
Occupation Non-manual 0.82 0.68 0.69 0.62 0.63 0.62 0.53**
Manual 0.78 0.69 0.64 0.56 0.59 0.55 0.38**
Other 0.84 0.71 0.65 0.64 0.63 0.62 0.50**
Monthly income <2.5 million won 0.81 0.69 0.64 0.62 0.58 0.57 0.34*
2.5–5.0 million won 0.80 0.68 0.64 0.57 0.60 0.58 0.48*
≥5.0 million won 0.88 0.76 0.78 0.72 0.71 0.72 0.48*
Ambulatory care visit in the past 2 weeks Yes 0.79 0.68 0.68 0.58 0.60 0.58 0.35
No 0.81 0.69 0.65 0.60 0.61 0.59 0.46
Hospitalization in the past 12 months Yes 0.84 0.74 0.75 0.68 0.60 0.63 0.30
No 0.81 0.69 0.65 0.60 0.61 0.59 0.46
Morbidity Yes 0.80 0.69 0.70 0.64 0.59 0.56 0.42
No 0.81 0.69 0.65 0.59 0.61 0.59 0.45

*P-value < 0.05, **P-value < 0.01.

HS: health state; SD: standard deviation.

HS1: Adenomatous polyps; HS2: Colon cancer requiring colon resection; HS3: Rectal cancer requiring resection of the rectum; HS4: Colon cancer requiring colon resection and systemic chemotherapy; HS5: Rectal cancer requiring resection of the rectum and chemoradiation therapy; HS6: Rectal cancer requiring resection of the rectum, stoma formation, and chemoradiation therapy; HS7: Metastatic colon cancer.